S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea · Delayed Price · Currency is KRW 27,650
+1,050 (3.95%)
At close: Apr 9, 2026
S.Biomedics Revenue
In the year 2025, S.Biomedics had annual revenue of 16.55B KRW with 20.49% growth. S.Biomedics had revenue of 4.03B in the quarter ending December 31, 2025, a decrease of -9.35%.
Revenue
16.55B
Revenue Growth
+20.49%
P/S Ratio
20.99
Revenue / Employee
n/a
Employees
n/a
Market Cap
347.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.55B | 2.81B | 20.49% |
| Dec 31, 2024 | 13.73B | 625.65M | 4.77% |
| Dec 31, 2023 | 13.11B | 995.73M | 8.22% |
| Dec 31, 2022 | 12.11B | 3.24B | 36.58% |
| Dec 31, 2021 | 8.87B | 3.55B | 66.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HansBiomed | 100.17B |
| NIBEC | 32.72B |
| Genome & Company | 24.59B |
| Bio Solution | 15.20B |
| TiumBio | 12.29B |
| Kangstem Biotech | 3.57B |
| Y-Biologics | 2.91B |
| IntoCell | 2.30B |